Balancing the scale: the role of oral anticoagulants in atrial fibrillation

Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.

Best of the west: meet PSA’s newest award winners

Four pharmacists were crowned the best of the west at PSA’s West Australian Annual Therapeutic Update (ATU) last weekend.

The trial that could revolutionise medicine safety

Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.

Report any CAM adverse effects, warns Dr Geraldine Moses

Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.

TGA approves Pfizer booster for teens

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Pharmacists scramble to protect remote communities from COVID-19

Clusters of infection in regional and remote areas continue to grow, with overworked pharmacists adapting their services to minimise the spread.